Clinical validation of MyCog for cognitive impairment detection in primary care, highlighting effective screening methods.
Background Primary care offers ideal opportunities for early detection of cognitive impairment, yet clinics face significant barriers to routine screening. MyCog is an electronic health record–integrated tablet application self‐administered during a primary care visit designed to overcome barriers to screening. Methods We compared MyCog performance between 65 adults age 65+ with diagnosed cognitive impairment and 80 cognitively normal adults. Five modeling approaches achieved consensus to select consistently discriminative variables for the final detection algorithm. Performance was primarily assessed via receiver operating characteristic area under the curve (AUC), sensitivity, specificity, and accuracy. Results All models demonstrated strong diagnostic performance (AUC 0.817 to 0.873). Memory accuracy and executive function efficiency scores were consistently selected as predictors of impairment across models. The final logistic regression achieved AUC 0.890, with sensitivity 0.723 to 0.831, specificity 0.788 to 0.912, and accuracy 0.807 to 0.828 depending on threshold. Discussion Findings suggest MyCog accurately detects cognitive impairment via a streamlined self‐administered app that efficiently fits into primary care workflows.
No takes yet. Share an insight, caveat, or question.
Young et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: